ENvue Medical, Inc. (FEED) stock
Close on Oct 19, 2026Market cap $3.08MP/E –Yield –
ENvue Medical, Inc. saw revenue fall 17.7% to $1.93M over the twelve months to Jun 30, 2026. Free cash flow was -$11.74M. At the latest close the market valued the company at $3.08M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $3.08M
- P/E ratio
- –
- Price to sales
- 1.60
- Price to book
- 0.10
- Dividend yield
- –
- Free cash flow yield
- -381.47%
Fundamentals
- Revenue
- $1.93M
- Net income
- -$21.06M
- EPS, diluted
- -$26.69
- Free cash flow
- -$11.74M
- Book value per share
- $5.00
- Diluted shares
- 6M
Trading
- Previous close
- $0.37
- Open
- $0.54
- Day's range
- $0.39 – $0.54
- Volume
- 4,139
- Average volume (20 days)
- 12,699
Market cap history
Month-end market cap since 2015, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | FEED | S&P 500 | Difference | FEED per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -32.8% | +0.6% | −33.5 pts | ||
| 3 months | -90.0% | +3.4% | −93.4 pts | ||
| Year to date | -98.2% | +13.3% | −111.5 pts | ||
| 1 year | -99.3% | +16.6% | −115.9 pts | ||
| 3 years | -100.0% | +86.4% | −186.3 pts | -93.0% | +23.1% |
| 5 years | -100.0% | +81.9% | −181.9 pts | -89.7% | +12.7% |
| 10 years | -100.0% | +318.9% | −418.9 pts | -71.6% | +15.4% |
Thirteen years at a glance
Fiscal years 2013 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases ENvue Medical filed with the SEC as exhibits to Form 8-K or 6-K
- News
- Update
- Update
- Announces Pricing of $2.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesNews
- News
- News
About ENvue Medical
Orthopedic, Prosthetic & Surgical Appliances & Supplies
ENvue Medical, Inc. develops, manufactures, and markets medical devices specializing in enteral feeding navigation and non-invasive therapeutic solutions. Its core offering is the ENvue System, an electromagnetic navigation platform that guides clinicians in the real-time placement and verification of enteral feeding tubes into the stomach or small intestine of adult hospital patients. Alongside the navigation console, the company provides proprietary single-use feeding tubes and related accessories such as syringes. Through its subsidiary NanoVibronix Ltd., the company also develops wearable, non-invasive acoustic devices for biofilm prevention and pain therapy, designed for direct patient use at home without medical professional oversight.
Company profile, executives and historyENvue Medical stock: common questions
What is ENvue Medical's stock price?
FEED closed at $0.50 on Oct 19, 2026, up 34.73% on the day.
What is ENvue Medical's market cap?
ENvue Medical was worth $3.08M at the close on Oct 19, 2026: the share price times the diluted shares outstanding.
What is FEED's P/E ratio?
ENvue Medical lost money over fiscal 2025 (diluted EPS -$26.69), so it has no meaningful P/E ratio.
How much revenue does ENvue Medical make?
ENvue Medical reported revenue of $1.93M for the twelve months to Jun 30, 2026, down 17.7% from a year earlier.
Does ENvue Medical pay a dividend?
No. ENvue Medical has not paid a cash dividend over the last twelve months.
How has FEED stock performed over the past year?
Including dividends, FEED returned -99.3% over the past year, against +16.6% for the S&P 500.
Who are ENvue Medical's competitors?
Companies most similar to ENvue Medical by business, industry and size include NTRB, CLGN, VJET, FEMY, VYCO.
See a number that looks wrong?